U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H24O2
Molecular Weight 272.382
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 19-NORANDROSTENEDIONE

SMILES

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CCC2=O

InChI

InChIKey=JRIZOGLBRPZBLQ-QXUSFIETSA-N
InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-16H,2-9H2,1H3/t13-,14+,15+,16-,18-/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H24O2
Molecular Weight 272.382
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Estranediols profiling in calves' urine after 17beta-nandrolone laureate ester administration.
2010-08
Novel steroid-sensing model and characterization of protein interactions based on fluorescence anisotropy decay.
2010-04-01
Influence of delivery mode on the urinary excretion of nandrolone metabolites.
2010-04
Biochemical and physiological aspects of endogenous androgens.
2010
Steroid metabolism in chimeric mice with humanized liver.
2009-11
Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration--analysis of side effects and metabolism.
2009-07-24
Urinary nandrolone metabolite detection after ingestion of a nandrolone precursor.
2009-04
Two homologous fungal carbonyl reductases with different substrate specificities.
2009-03-16
Doping in sport: 3. Metabolic conversion of oral norethisterone to urinary 19-norandrosterone.
2009-03
Doping in sport--2. Quantification of the impurity 19-norandrostenedione in pharmaceutical preparations of norethisterone.
2009-03
A new mixed micellar electrokinetic chromatography method for analysis of natural and synthetic anabolic steroids.
2009-01-15
Gene expression in hair follicle dermal papilla cells after treatment with stanozolol.
2008-12-23
Micronucleus induction in V79 cells by the anabolic doping steroids desoxymethyltestosterone (madol) and 19-norandrostenedione.
2008-12-15
Elimination kinetic of 17beta-estradiol 3-benzoate and 17beta-nandrolone laureate ester metabolites in calves' urine.
2008-05
Profiling of 19-norsteroid sulfoconjugates in human urine by liquid chromatography mass spectrometry.
2008-04-21
The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration.
2008-04-01
The presence of 19-norandrostenedione and its sulphate form in yolk-sac fluid of the early equine conceptus.
2008-01
Microbial oxidation of anabolic steroids.
2008
Synthesis and analytics of 2,2,3,4,4-d5-19-nor-5alpha-androsterone--an internal standard in doping analysis.
2007-05
Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
2007-04
Studies related to the origin of C18 neutral steroids isolated from extracts of urine from the male horse: the identification of urinary 19-oic acids and their decarboxylation to produce estr-4-en-17beta-ol-3-one (19-nortestosterone) and estr-4-ene-3,17-dione (19-norandrost-4-ene-3,17-dione) during sample processing.
2007-03-14
Survey of nutritional supplements for selected illegal anabolic steroids and ephedrine using LC-MS/MS and GC-MS methods, respectively.
2007-03
Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects.
2006-11
Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids.
2006-09
Dimerization and enzymatic activity of fungal 17beta-hydroxysteroid dehydrogenase from the short-chain dehydrogenase/reductase superfamily.
2005-12-16
Transformations of 4- and 17alpha-substituted testosterone analogues by Fusarium culmorum.
2005-11
Endogenous occurrence of some anabolic steroids in swine matrices.
2005-09
Unintentional doping through the use of contaminated nutritional supplements.
2005-07
Quantification and profiling of 19-norandrosterone and 19-noretiocholanolone in human urine after consumption of a nutritional supplement and norsteroids.
2005-03
Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements.
2004-07
Significance of individual amino acid residues for coenzyme and substrate specificity of 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus.
2003-02-01
Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits?
2003-02
Effects of norandrostenedione and norandrostenediol in resistance-trained men.
2002-09
Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control.
2002-01-25
[Urinary nandrolone metabolites in antidoping control].
2001-09
Detection and determination of anabolic steroids in nutritional supplements.
2001-07
The effects of supplementation with 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol on body composition and athletic performance in previously weight-trained male athletes.
2001-05
The metabolism of orally ingested 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol in healthy, resistance-trained men.
2001-02
17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus: structural and functional aspects.
2001-01-30
Searching for the physiological function of 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus: studies of substrate specificity and expression analysis.
2001-01-22
Consequence of boar edible tissue consumption on urinary profiles of nandrolone metabolites. II. Identification and quantification of 19-norsteroids responsible for 19-norandrosterone and 19-noretiocholanolone excretion in human urine.
2001
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:08:59 GMT 2025
Edited
by admin
on Mon Mar 31 18:08:59 GMT 2025
Record UNII
U90987PVU5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
19-NORANDROSTENEDIONE
Common Name English
NSC-12164
Preferred Name English
19-NOR-4-ANDROSTENE-3,17-DION
Systematic Name English
19-NOR-4-ANDROSTENEDIONE
Code English
4-OESTREN-3,17-DIONE
Systematic Name English
NORETHISTERONE IMPURITY B [EP IMPURITY]
Common Name English
4-OESTRENDIONE
Common Name English
4-NORENDION
Common Name English
ESTR-4-ENE-3,17-DIONE
Systematic Name English
NORETHINDRONE RELATED COMPOUND B [USP-RS]
Common Name English
19-NOR-4-ANDROSTENE-3,17-DIONE
Systematic Name English
4-NORENDIONE
Common Name English
19-NORANDROST-4-ENE-3,17-DIONE
Common Name English
NORDIONE
Common Name English
(+)-19-NORANDROST-4-EN-3,17-DIONE
Common Name English
19-NORANDROST-4-EN-3,17-DIONE
Systematic Name English
NORETHISTERONE ACETATE IMPURITY J [EP IMPURITY]
Common Name English
Classification Tree Code System Code
DEA NO. 4000
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
Code System Code Type Description
MESH
C002828
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
CAS
734-32-7
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
ECHA (EC/EINECS)
211-995-8
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
DRUG BANK
DB01448
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
SMS_ID
100000091511
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
EVMPD
SUB25857
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
WIKIPEDIA
19-NORANDROSTENEDIONE
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
RS_ITEM_NUM
1470026
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
FDA UNII
U90987PVU5
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
NSC
12164
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
PUBCHEM
92834
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
EPA CompTox
DTXSID50862392
Created by admin on Mon Mar 31 18:08:59 GMT 2025 , Edited by admin on Mon Mar 31 18:08:59 GMT 2025
PRIMARY
Related Record Type Details
METABOLITE -> PARENT
MAJOR
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY